INS and metabolic dysfunction-associated steatotic liver disease: We found HMGCR also involved in insulin secretion and glucose homeostasis, previous study suggested that the increased risk of type2 diabetes noted with statins was partially explained by HMGCR inhibition [24], inferring that HMGCR could be the potential medium between the glucose and lipid metabolism in NAFLD.